
CS II Forte Injection
Marketer
Zyphar's Pharmaceuticals Pvt Ltd
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview CS II Forte Injection
Combiforte Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism halts microbial proliferation and infection spread. Administration must be overseen by a qualified medical professional. Consistent adherence to the prescribed dosage schedule is vital; complete the entire course, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Ample rest, a nutritious diet, and hydration are crucial for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of CS II Forte Injection
There is no text provided to rephrase.
Uses of CS II Forte Injection
Managing bacterial infections
Major Benefits of CS II Forte Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of CS II Forte Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use CS II Forte Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How CS II Forte Injection works:
CS II Forte Injection unites Cefoperazone, a bacterial cell wall synthesis inhibitor antibiotic, and Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism disrupts bacterial cell wall formation, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance, thereby bolstering Cefoperazone's antibacterial efficacy.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during treatment with CS II Forte Injection can lead to adverse reactions including facial redness, rapid pulse, vomiting, dehydration, chest discomfort, and hypotension (a Disulfiram-like response).
PregnancySAFE IF PRESCRIBED
Administration of CS II Forte Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
CS II Forte Injection poses minimal risk to breastfeeding infants. Research in humans indicates negligible transfer of the medication into breast milk, rendering it unlikely to harm the nursing child.
DrivingCONSULT YOUR DOCTOR
The effect of CS II Forte Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of CS II Forte Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of CS II Forte Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take CS II Forte Injection :
Omit a scheduled CS II Forte Injection? Seek your physician's advice.
Facts to Know About CS II Forte Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
